Intra-aortic balloon pump still has a role in late-onset myocardial infarction complicated by ventricular septal rupture with intractable heart failure: a case report.

BACKGROUND: The current guidelines have discouraged the routine use of intra-aortic balloon pump (IABP) in cardiogenic shock complicating acute coronary syndrome (ACS). Since then, the trend of IABP utilization in ACS has been declining. Nevertheless, the guidelines still preserve the recommendation of IABP use in hemodynamic instability or cardiogenic shock caused by post myocardial infarction (MI) ventricular septal rupture (VSR). CASE PRESENTATION: A 46-years-old diabetic Southeast Asian female was referred from a peripheral facility with intractable heart failure despite treatment with vasoactive agents and diuretics for five days. The ECG suggested a recent anteroseptal myocardial infarction with normal high-sensitivity troponin-I value. The echocardiography detected a regional wall motion abnormality and a 10 mm wide ventricular septal defect. Invasive coronary angiography revealed a severe two-vessel coronary artery disease. We planned a delayed surgical strategy with preoperative optimization using IABP as a bridge to surgery. IABP implantation followed by significant hemodynamic improvement and rapid resolution of heart failure without any inotrope support. Afterwards, coronary artery bypass grafting (CABG) and VSR surgical repair were performed. We safely removed IABP on the third postoperative day with proper weaning and minimal vasoactive support. CONCLUSION: We report a case where IABP still provided benefits for a patient with intractable heart failure caused by undetermined onset MI complicated by VSR. The use of IABP in such a case is in accordance with the recommendation of the current guidelines. Several studies showed that IABP use during preoperative optimization in the case of post-MI VSR was associated with survival benefits.

Technical aspect in renal artery embolization in renal tumors: A case series.

INTRODUCTION: Renal artery embolization aims to reduce blood loss during surgery. Various embolizing agents are available, each of which has its own indications appropriate for various vascular anatomy and renal pathology. PRESENTATION OF CASE: We report three cases of renal artery embolization prior to surgical nephrectomy using vascular plug and other embolizing agents. In two cases, complete blood flow occlusion was achieved with minimal blood loss during the subsequent surgery. One case only achieved reduced blood flow, but subsequent nephrectomy and patient recovery was successful. DISCUSSION: Renal artery embolization prior to malignant mass resection is a well-known, potentially beneficial procedure. The rationale that supports this procedure is clear, but its reported outcome in the literature is still inconclusive. It is important to understand its benefits, complications, and pitfalls to achieve better outcome. CONCLUSION: In our cases, renal artery embolization provided satisfactory reduction in bleeding during nephrectomy, and therefore has the potential to be employed as a standard procedure for future surgeries.

Performing cardiac surgery during COVID-19 pandemic in Surabaya, Indonesia: A single-center retrospective observational study.

BACKGROUND: Healthcare workers are still the front liners in health care services, and have major roles during the COVID-19 pandemic. In a resource-limited country like Indonesia, it is necessary to provide safe screening and management both for patients and healthcare workers to minimize the transmission. We report our experience in the cardiac surgery department on how to provide safe management during the COVID-19 pandemic. METHODS: A retrospective observational study was performed in a single-tertiary-center cardiac surgery department in Surabaya and included all patients who underwent cardiac surgery during the first year of the COVID-19 pandemic. We also collected the patients from a 1-year period before the pandemic as the comparison data. Analysis of the patient characteristics, operative data, and postoperative outcome, was performed. This study also provides our experience in changes of admission in the cardiac surgery preoperative system that can be utilized for others. RESULTS: A total of 179 patients were admitted to and had cardiac surgery. Of these, 3.80% (n = 7) were COVID-19 confirmed by a real-time polymerase chain reaction. Five patients were delayed to have cardiac surgery with no mortality or morbidity reported in these patients. During the period after changes of admission procedural in cardiac surgery patients, there were no healthcare workers infected by COVID-19 by patient transmission in our center (0%). CONCLUSION: Our study reported a systematic screening and that possible delay in cardiac surgery appears to be feasible and safe, both for patients and for healthcare workers during the COVID-19 pandemic.